In this study, the potential interaction between ADSCs and breast cancer cells was investigated, implicating CXCL5, a breast cancer-associated chemokine24–30, to be a mediator that promotes malignant behaviors of breast cancer cells under the paradigm of resistin-stimulated ADSCs. Here, CXCL5 is linked to breast carcinoma.